National Cancer Institute, Research Contracts Branch, PCCS, Executive Plaza South, Room 635, Bethesda, Md 20892

A -- A PHASE I NON-RANDOMIZED MULTIPLE-DOSE SAFETY, PHARMACOLINETIC AND PHARMACODYNAMIC (BIOMARKER MODULATION) STUDY OF AN ANTIESTROGEN IN WOMEN WITH NEWLY DIAGNOSED BREASE CANCER POC Schyuler T. Eldridge, Contract Specialist, 301-435-3794; Theresa H. Shroff, Contracting Officer, 301-435-3796. CNT N01-CN-85035 AMT $2,782,847 DTD 120497 TO University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160 E-MAIL: Schuyler T. Eldridge, eldridges@rcb.nci.nih.gov. (0342)

Loren Data Corp. http://www.ld.com (SYN# 0313 19971210\A-0005.AWD)